Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
L-carnitine for treatment of anemia in chronic kidney disease
IRCT20180921041080N1Phase 3Completed
- Sponsor
- Kurdistan University of Medical Sciences
- Start
- Aug 2018
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of levocarnitine in anaemia and chronic kidney disease (CKD), sponsored by Kurdistan University of Medical Sciences. Started Aug 2018; status: completed.
02
Drugs
levocarnitine
03
Conditions
anaemiachronic kidney disease (CKD)
Beyond the preview
Go deeper on IRCT20180921041080N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20180921041080N1.